Qing S Zhang, 572800 S Columbia Rd UNIT 416, Grand Forks, ND 58201

8209342, Jun 26, 2012

Oct 31, 2008

12/262706

Divesh Srivastava - Summit NJ, US
Nikolaos Koudas - Ontario, CA
Ting Yu - Cary NC, US
Qing Zhang - Torrance CA, US

AT&T Intellectual Property I, LP - Reno NV

G06F 17/30

707757

A data structure that includes at least one partition containing non-confidential quasi-identifier microdata and at least one other partition containing confidential microdata is formed. The partitioned confidential microdata is disguised by transforming the confidential microdata to conform to a target distribution. The disguised confidential microdata and the quasi-identifier microdata are combined to generate a disguised data structure. The disguised data structure is used to carry out statistical analysis and to respond to a statistical query is directed to the use of confidential microdata. In this manner, the privacy of the confidential microdata is preserved.

2008015, Jun 26, 2008

Dec 19, 2007

11/959536

Ping Qiu - Edison NJ, US
Jonathan Richard Greene - South Orange NJ, US
Wei Ding - Scotch Plains NJ, US
Qing Zhang - Short Hills NJ, US

G06G 7/58

703 11

The present invention relates to a method for developing algorithms that are capable of discriminating among different genotypes and subtypes of a virus of interest. The method includes aligning a set of viral nucleotide sequences having known genotypes and analyzing the aligned sequences to identify nucleotide positions at which the nucleotide is conserved within genotypes, but diversified across the different known genotypes. These positions, referred to herein as genotyping positions, are employed as predictive variables to compile a variable input table for analysis by a statistical classification algorithm. The variable input table also includes the nucleotide present at each genotyping position as a value and the genotype for each of the aligned sequences as a response variable. The algorithm analyzes the sequences of nucleotides at the genotyping positions across the aligned viral sequences, and uses the results of this analysis to specify parameters for each genotyping position that when combined across the genotyping positions will discriminate among the genotypes represented in the input sequences. The algorithm generated by this method is useful in a method of predicting the genotype of a viral isolate of interest, such as a virus present in a biological sample obtained from an individual.

2011015, Jun 23, 2011

May 21, 2009

12/993672

Qing Zhang - Short Hills NJ, US
Nicholas J. Murgolo - Millington NJ, US
Joseph A. Hedrick - South River NJ, US

A61K 39/395
A61K 38/16
G01N 33/50
C07K 14/00
C07K 16/00
C12N 9/50
C12N 9/16
C12N 9/22
A61P 9/10
A61P 3/06

4241341, 514 74, 436 86, 530350, 5303873, 435219, 435196, 435199

The present invention provides, in part, methods and compositions for treating lipid disorders comprising administering a polypeptide that inhibits PCSK9. A novel method for identifying polypeptides that interact with PCSK9 is also provided.

5810539, Sep 22, 1998

Apr 5, 1996

8/628527

Ruyu Zhang - Flushing NY
Qing Zhang - Flushing NY

E04H 612

414239

A device for the efficient parking of vehicles is provided. The device includes: 1) a car-pan comprised of steel plate; 2) strengthening rods on the car-pan; 3) a parking space frame comprising a pair of steel C bars as its side beams and another pair of steel C bars as its end beams; 4) a number of (preferably two set) of free rollers with supports; 5) two pairs of driving rollers; 6) a parking power/control box affixed between the two side beams of the parking space; 7) chains connecting the driving rollers with the parking power/control box; 8) an elevator; 9) vertical rack-rails located at the two sides of the elevator; 10) an elevator power/control box affixed between the two side beams of the elevator; and 11) two pairs of chains connecting the driving rollers and the climbing gears of the elevator power/control box. The present device may further include 12) four cables with connectors, and 13) two balance weights between the vertical rack-rails.

2014020, Jul 24, 2014

Jun 22, 2012

14/127699

Youyi Peng - New York NY, US
Lawrence P. Wennogle - New York NY, US
Qing Zhang - New York NY, US
John Tomesch - New York NY, US

C07D 401/12
A61K 45/06
A61K 31/454

4241331, 514326, 514 49, 424649, 514283

It is an object of the present invention that the novel nicotinic receptor antagonists disclosed herein may be used in a broad array of clinical or medicinal facets. For example, it is a contemplated use of the present invention that the novel nicotinic receptor antagonists be used to inhibit the growth cycle of non-small cell lung cancer cells. Without being bound by theory, it is an object of the present invention that the nicotinic receptor antagonists disclosed herein are believed to possess reversible binding properties. Moreover, the compounds of the present invention are selective for 0.7 nAChR. For example, the compounds of the present invention are not believed to bind to 0.4 (32 nAChR neuromuscular receptors. It is also contemplated that the nicotinic receptor antagonists of the present invention will be used as a counter measure to treat exposure, or potential exposure, to a wide array of potential neurotoxins.